
Nephros, Inc.
NEPHNASDAQHealthcareMedical - Instruments & Supplies
Latest quote
$4.15
−$0.325 · -7.38%
NEPH company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
76
Undervalued
Momentum
36
Weakening
Sentiment
68
Bullish
Risk resilience
24
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteNephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreation, commercial establishments, and various other healthcare facilities. The Pathogen Detection segment focuses on developing and distributing real-time water testing systems, which deliver critical, actionable data regarding waterborne pathogens. Furthermore, under its Renal Products segment, the company provides medical devices designed for individuals suffering from renal disease, notably including a second-generation hemodiafiltration system tailored for patients with end-stage renal disease. Additionally, Nephros markets a range of water filters under the Nephros and AETHER brands. These filters are engineered not only to enhance water taste and eliminate odors but also to significantly reduce biofilm, bacteria, and scale accumulation in downstream equipment, serving the food service, hospitality, convenience store, and healthcare industries. Established in 1997, Nephros, Inc. maintains its corporate headquarters in South Orange, New Jersey.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Robert Banks
- Listed since
- Sep 21, 2004
- Employees
- 36
Market position
- Volume
- 100.71K
- 4.99× average
- Average volume
- 20.17K
- Average daily volume
- Market cap
- 44.29M USD
- Beta
- 1.53
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- 25.39×
- P/B (TTM)
- 3.7×
- P/S (TTM)
- 2.14×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 60.31%
- Operating margin
- 7.92%
- Net margin
- 8.38%
Financial health
- Debt / equity
- 0.07×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 18.79M USD | 14.16M USD | 14.24M USD | 9.98M USD | 10.22M USD |
| Cost of goods sold | 7.3M USD | 5.44M USD | 5.83M USD | 5.24M USD | 4.58M USD |
| Gross profit | 11.49M USD | 8.72M USD | 8.41M USD | 4.73M USD | 5.63M USD |
| Research and development | 1.34M USD | 906K USD | 873K USD | 1.26M USD | 1.5M USD |
| Selling, general, and administrative | 9M USD | 7.68M USD | 8.91M USD | 7.59M USD | 7.2M USD |
| Operating expenses | 10.34M USD | 8.72M USD | 10M USD | 9.07M USD | 8.89M USD |
| Interest income | 139K USD | 94K USD | 64K USD | 14K USD | 10K USD |
| Interest expense | 1K USD | 1K USD | 2K USD | 20K USD | 41K USD |
| Depreciation and amortization | 140K USD | 137K USD | 214K USD | 571K USD | 252K USD |
| Operating income | 1.15M USD | 6K USD | −1.59M USD | −4.34M USD | −3.25M USD |
| Net income | 1.19M USD | 74K USD | −1.58M USD | −7.38M USD | −4.11M USD |
Company facts updated Aug 24, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$4.00
1.96% downsideRating distribution
4 ratingsLimited analyst sample: 4 ratings. Interpret the distribution with caution.
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jul 10, 2019 | 1:9 | — | — |
Stock split | Mar 17, 2011 | 1:20 | — | — |
Effective Jul 10, 2019
1:9
Effective Mar 17, 2011
1:20
NEPH peers
ETFs holding NEPH
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI443.75K0.00%2.3T USD0.03%$378.24+0.44%
Vanguard Extended Market ETFVXF229.65K0.00%93.7B USD0.05%$245.53+0.82%
iShares Micro-Cap ETFIWC79.18K0.01%1.53B USD0.60%$198.39+1.10%
Dimensional - US Core Equity 2 ETFDFAC21.19K0.00%49.31B USD0.17%$45.61+0.46%
Dimensional - US Core Equity 1 ETFDCOR10.85K0.00%3.51B USD0.14%$84.54+0.42%
Dimensional - US Sustainability Core 1 ETFDFSU1.8K0.00%2.35B USD0.15%$48.20+0.52%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 443.75K
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Extended Market ETFVXF- Market value
- 229.65K
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Micro-Cap ETFIWC- Market value
- 79.18K
- Weight
- 0.01%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39+1.10%
Dimensional - US Core Equity 2 ETFDFAC- Market value
- 21.19K
- Weight
- 0.00%
- AUM
- 49.31B USD
- Expense ratio
- 0.17%
- Price / 1D
- $45.61+0.46%
Dimensional - US Core Equity 1 ETFDCOR- Market value
- 10.85K
- Weight
- 0.00%
- AUM
- 3.51B USD
- Expense ratio
- 0.14%
- Price / 1D
- $84.54+0.42%
Dimensional - US Sustainability Core 1 ETFDFSU- Market value
- 1.8K
- Weight
- 0.00%
- AUM
- 2.35B USD
- Expense ratio
- 0.15%
- Price / 1D
- $48.20+0.52%
Continue in GoAI
Research NEPHresearch.disclaimer





